Abstract
Prostaglandin E2 (PGE2) is a key proinflammatory mediator that contributes to inflammatory hyperalgesia. Voltage-gated sodium channel 1.7 (Nav1.7) plays an important role in inflammatory pain. However, the modulation of Nav1.7 in inflammatory pain remains poorly understood. We hypothesized that PGE2 might regulate Nav1.7 expression in inflammatory pain. We here showed that treatment of rat trigeminal ganglion (TG) explants with PGE2 significantly upregulated the mRNA and protein expressions of Nav1.7 through PGE2 receptor EP2. This finding was confirmed by studies on EP2-selective antagonist PF-04418948. We also demonstrated that Nav1.7 and COX-2 expressions, as well as PGE2 levels, were upregulated in the TG after induction of rats’ temporomandibular joint (TMJ) inflammation. Correspondingly, hyperalgesia, as indicated by head withdrawal threshold, was observed. Moreover, TMJ inflammation-induced upregulation of Nav1.7 expression and PGE2 levels in the TG could be reversed by COX-2-selective inhibitor meloxicam given by oral gavage, and meanwhile, the hyperalgesia of inflamed TMJ was also mitigated. So we concluded that PGE2 upregulated trigeminal ganglionic Nav1.7 expression to contribute to TMJ inflammatory pain in rats. Our finding suggests that PGE2 was an important regulator of Nav1.7 in TMJ inflammatory pain, which may help increase understanding on the hyperalgesia of peripheral inflammation and develop a new strategy to address inflammatory pain.
Similar content being viewed by others
References
Toledo-Aral, J.J., B.L. Moss, Z.J. He, A.G. Koszowski, T. Whisenand, S.R. Levinson, J.J. Wolf, I. Silos-Santiago, S. Halegoua, and G. Mandel. 1997. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proceedings of the National Academy of Sciences of the United States of America 94: 1527–1532.
Cummins, T.R., J.R. Howe, and S.G. Waxman. 1998. Slow closed-state inactivation: A novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. The Journal of Neuroscience 18: 9607–9619.
Waxman, S.G. 2006. Neurobiology: A channel sets the gain on pain. Nature 444: 831–832.
Yang, Y., Y. Wang, S. Li, Z. Xu, H. Li, L. Ma, J. Fan, D. Bu, B. Liu, Z. Fan, G. Wu, J. Jin, B. Ding, X. Zhu, and Y. Shen. 2004. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. Journal of Medical Genetics 41: 171–174.
Fertleman, C.R., M.D. Baker, K.A. Parker, S. Moffatt, F.V. Elmslie, B. Abrahamsen, J. Ostman, N. Klugbauer, J.N. Wood, R.M. Gardiner, and M. Rees. 2006. SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes. Neuron 52: 767–774.
Cox, J.J., F. Reimann, A.K. Nicholas, G. Thornton, E. Roberts, K. Springell, G. Karbani, H. Jafri, J. Mannan, Y. Raashid, L. Al-Gazali, H. Hamamy, E.M. Valente, S. Gorman, R. Williams, D.P. McHale, J.N. Wood, F.M. Gribble, and C.G. Woods. 2006. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444: 894–898.
Black, J.A., S. Liu, M. Tanaka, T.R. Cummins, and S.G. Waxman. 2004. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108: 237–247.
Nassar, M.A., L.C. Stirling, G. Forlani, M.D. Baker, E.A. Matthews, A.H. Dickenson, and J.N. Wood. 2004. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proceedings of the National Academy of Sciences of the United States of America 101: 12706–12711.
Yeomans, D.C., S.R. Levinson, M.C. Peters, A.G. Koszowski, A.Z. Tzabazis, W.F. Gilly, and S.P. Wilson. 2005. Decrease in inflammatory hyperalgesia by herpes vector-mediated knockdown of Nav1.7 sodium channels in primary afferents. Human Gene Therapy 16: 271–277.
Gould, H.R., T.N. Gould, J.D. England, D. Paul, Z.P. Liu, and S.R. Levinson. 2000. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Research 854: 19–29.
Tamura, R., T. Nemoto, T. Maruta, S. Onizuka, T. Yanagita, A. Wada, M. Murakami, and I. Tsuneyoshi. 2014. Up-regulation of NaV1.7 sodium channels expression by tumor necrosis factor-alpha in cultured bovine adrenal chromaffin cells and rat dorsal root ganglion neurons. Anesthesia and Analgesia 118: 318–324.
Kidd, B.L., and L.A. Urban. 2001. Mechanisms of inflammatory pain. British Journal of Anaesthesia 87: 3–11.
O'Banion, M.K. 1999. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Critical Reviews in Neurobiology 13: 45–82.
Coleman, R.A., W.L. Smith, and S. Narumiya. 1994. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacological Reviews 46: 205–229.
Reinold, H., S. Ahmadi, U.B. Depner, B. Layh, C. Heindl, M. Hamza, A. Pahl, K. Brune, S. Narumiya, U. Muller, and H.U. Zeilhofer. 2005. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. The Journal of Clinical Investigation 115: 673–679.
Brune, K., and P. Patrignani. 2015. New insights into the use of currently available non-steroidal anti-inflammatory drugs. Journal of Pain Research 8: 105–118.
England, S., S. Bevan, and R.J. Docherty. 1996. PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. The Journal of Physiology 495 (Pt 2): 429–440.
Gold, M.S., D.B. Reichling, M.J. Shuster, and J.D. Levine. 1996. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proceedings of the National Academy of Sciences of the United States of America 93: 1108–1112.
Tripathi, P.K., C.G. Cardenas, C.A. Cardenas, and R.S. Scroggs. 2011. Up-regulation of tetrodotoxin-sensitive sodium currents by prostaglandin E(2) in type-4 rat dorsal root ganglion cells. Neuroscience 185: 14–26.
Ren, K. 1999. An improved method for assessing mechanical allodynia in the rat. Physiology & Behavior 67: 711–716.
Wu, Y.W., Y.P. Bi, X.X. Kou, W. Xu, L.Q. Ma, K.W. Wang, Y.H. Gan, and X.C. Ma. 2010. 17-Beta-estradiol enhanced allodynia of inflammatory temporomandibular joint through upregulation of hippocampal TRPV1 in ovariectomized rats. The Journal of Neuroscience 30: 8710–8719.
Kou, X.X., Y.W. Wu, Y. Ding, T. Hao, R.Y. Bi, Y.H. Gan, and X. Ma. 2011. 17beta-estradiol aggravates temporomandibular joint inflammation through the NF-kappaB pathway in ovariectomized rats. Arthritis and Rheumatism 63: 1888–1897.
Pairet, M., J. van Ryn, H. Schierok, A. Mauz, G. Trummlitz, and G. Engelhardt. 1998. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer. Inflammation Research 47: 270–276.
Gould, H.R., J.D. England, R.D. Soignier, P. Nolan, L.D. Minor, Z.P. Liu, S.R. Levinson, and D. Paul. 2004. Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund’s adjuvant-induced inflammation in rat. The Journal of Pain 5: 270–280.
Bi, R.Y., X.X. Kou, Z. Meng, X.D. Wang, Y. Ding, and Y.H. Gan. 2013. Involvement of trigeminal ganglionic Nav 1.7 in hyperalgesia of inflamed temporomandibular joint is dependent on ERK1/2 phosphorylation of glial cells in rats. European Journal of Pain 17: 983–994.
Zhao, P., S.G. Waxman, and B.C. Hains. 2007. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. The Journal of Neuroscience 27: 2357–2368.
Af, F.K., J. Root, T. Clarke, D. Davey, K. Aughton, K. Dack, and N. Pullen. 2011. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP(2) receptor antagonist. British Journal of Pharmacology 164: 1847–1856.
Rush, A.M., and S.G. Waxman. 2004. PGE2 increases the tetrodotoxin-resistant Nav1.9 sodium current in mouse DRG neurons via G-proteins. Brain Research 1023: 264–271.
Ferreira, S.H. 1972. Prostaglandins, aspirin-like drugs and analgesia. Nature: New Biology 240: 200–203.
Ferreira, S.H., and M. Nakamura. 1979. I—Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins 18: 179–190.
Chillingworth, N.L., S.G. Morham, and L.F. Donaldson. 2006. Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice. AJP: Regulatory, Integrative and Comparative Physiology 291: R327–R334.
Lin, C.R., F. Amaya, L. Barrett, H. Wang, J. Takada, T.A. Samad, and C.J. Woolf. 2006. Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. The Journal of Pharmacology and Experimental Therapeutics 319: 1096–1103.
Minami, T., H. Nakano, T. Kobayashi, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and S. Ito. 2001. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. British Journal of Pharmacology 133: 438–444.
Ueno, A., H. Matsumoto, H. Naraba, Y. Ikeda, F. Ushikubi, T. Matsuoka, S. Narumiya, Y. Sugimoto, A. Ichikawa, and S. Oh-ishi. 2001. Major roles of prostanoid receptors IP and EP(3) in endotoxin-induced enhancement of pain perception. Biochemical Pharmacology 62: 157–160.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant No. 81271173) and China International Science and Technology Cooperation (Grant No. 2013DFB30360).
Authors’ Contributions
YHG designed the study, analyzed the data, and wrote the manuscript. PZ conducted the study, analyzed the data, and wrote the manuscript. Both authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The experimental protocols utilized in the study were approved by the Animal Use and Care Committee of Peking University. The employed procedures were also consistent with the Ethical Guidelines of the International Association for the Study of Pain.
Conflict of Interest
The authors declare that they have no competing financial interests.
Rights and permissions
About this article
Cite this article
Zhang, P., Gan, YH. Prostaglandin E2 Upregulated Trigeminal Ganglionic Sodium Channel 1.7 Involving Temporomandibular Joint Inflammatory Pain in Rats. Inflammation 40, 1102–1109 (2017). https://doi.org/10.1007/s10753-017-0552-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-017-0552-2